Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells
Links shared publicly online about this topic.
- 552total visits
Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells
Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells
View full resource at content.karger.com
Tags: Cancer, Chemotherapy, Bladder Cancer, Urinary System
Most Recently Shared on January 26, 2011 at 6:21 pm By:
Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherap... http://bit.ly/fGJSti
Urology Article | Urinary Bladder
mdlinx.com — “Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells” View full resource at mdlinx.com
Most Recently Shared on August 24, 2011 at 10:46 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Ch... http://t.co/VLs67u6 #urology
Advertisement
